Development of DinQ from Escherichia coli as an anti-cell-envelope antibiotic

Int J Antimicrob Agents. 2015 Feb;45(2):196-7. doi: 10.1016/j.ijantimicag.2014.10.005. Epub 2014 Oct 31.

Authors

James A Booth¹, Rajikala Suganthan², Peter Gaustad², Magnar Bjørås³

Affiliations

¹ Department of Microbiology, Oslo University Hospital, University of Oslo, Postboks 4950 Nydalen, 0424 Oslo, Norway. Electronic address: james.booth@rr-research.no.
² Department of Microbiology, Oslo University Hospital, University of Oslo, Postboks 4950 Nydalen, 0424 Oslo, Norway.
³ Department of Microbiology, Oslo University Hospital, University of Oslo, Postboks 4950 Nydalen, 0424 Oslo, Norway. Electronic address: magnar.bjoras@rr-research.no.

PMID: 25465525
DOI: 10.1016/j.ijantimicag.2014.10.005

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / isolation & purification
Anti-Bacterial Agents / pharmacology*
Escherichia coli / chemistry*
Escherichia coli Proteins / isolation & purification
Escherichia coli Proteins / pharmacology*
Membrane Proteins / isolation & purification
Membrane Proteins / pharmacology*

Substances

Anti-Bacterial Agents
DinQ protein, E coli
Escherichia coli Proteins
Membrane Proteins